The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis
Open accessAbstract
Background—: The prognosis and treatment of the 2 main types of cardiac amyloidosis, immunoglobulin light chain (AL) and transthyretin (ATTR) amyloidosis, are substantially influenced by cardiac involvement. Cardiovascular magnetic resonance with late gadolinium enhancement (LGE) is a reference standard for the diagnosis of cardiac amyloidosis, but its potential for stratifying risk is unknown. Methods and Results—: Two hundred fifty prospectively recruited subjects, 122 patients with ATTR amyloid, 9 asymptomatic mutation carriers, and 119 patients with AL amyloidosis, underwent LGE cardiovascular magnetic resonance. Subjects were followed up for a mean of 24±13 months. LGE was performed with phase-sensitive inversion recovery (PSIR) and without (magnitude only). These were compared with extracellular volume measured with T1 mapping. PSIR was superior to magnitude-only inversion recovery LGE because PSIR always nulled the tissue (blood or myocardium) with the longest T1 (least gadolinium). LGE was classified into 3 patterns: none, subendocardial, and transmural, which were associated with increasing amyloid burden as defined by extracellular volume ( P <0.0001), with transitions from none to subendocardial LGE at an extracellular volume of 0.40 to 0.43 (AL) and 0.39 to 0.40 (ATTR) and to transmural at 0.48 to 0.55 (AL) and 0.47 to 0.59 (ATTR). Sixty-seven patients (27%) died. Transmural LGE predicted death (hazard ratio, 5.4; 95% confidence interval, 2.1–13.7; P <0.0001) and remained independent after adjustment for N-terminal pro-brain natriuretic peptide, ejection fraction, stroke volume index, E/E′, and left ventricular mass index (hazard ratio, 4.1; 95% confidence interval, 1.3–13.1; P <0.05). Conclusions—: There is a continuum of cardiac involvement in systemic AL and ATTR amyloidosis. Transmural LGE is determined reliably by PSIR and represents advanced cardiac amyloidosis. The PSIR technique provides incremental information on outcome even after adjustment for known prognostic factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Falk, R. H., Comenzo, R. L., & Skinner, M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709253371306 · Cited by 1,180
Dispenzieri, A., Gertz, M. A., Kyle, R. A., Lacy, M. Q., Burritt, M. F., Therneau, T. M., Greipp, P. R., Witzig, T. E., Lust, J. A., Rajkumar, S. V., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.03.029 · Cited by 985
Cardiovascular Magnetic Resonance in Cardiac Amyloidosis
Maceira, A. M., Joshi, J., Prasad, S. K., Moon, J. C., Perugini, E., Harding, I., Sheppard, M. N., Poole-Wilson, P. A., Hawkins, P. N., & Pennell, D. J. (2005) · Circulation · doi:10.1161/01.cir.0000152819.97857.9d · Cited by 982
Self-citationSystemic Cardiac Amyloidoses: Disease Profiles and Clinical Courses of the 3 Main Types
Rapezzi, C., Merlini, G., Quarta, C. C., Riva, L., Longhi, S., Leone, O., Salvi, F., Ciliberti, P., Pastorelli, F., Biagini, E., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.843334 · Cited by 774
Piechnik, S. K., Ferreira, V. M., Dall'Armellina, E., Cochlin, L. E., Greiser, A., Neubauer, S., & Robson, M. D. (2010) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-12-69 · Cited by 670
Role of Cardiac Magnetic Resonance Imaging in the Detection of Cardiac Amyloidosis
Syed, I. S., Glockner, J. F., Feng, D., Araoz, P. A., Martinez, M. W., Edwards, W. D., Gertz, M. A., Dispenzieri, A., Oh, J. K., Bellavia, D., et al. (2010) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2009.09.023 · Cited by 545
Evaluation of Systemic Amyloidosis by Scintigraphy with123I-Labeled Serum Amyloid P Component
Hawkins, P. N., Lavender, J. P., & Pepys, M. B. (1990) · New England Journal of Medicine · doi:10.1056/nejm199008233230803 · Cited by 533
Self-citationCardiovascular Magnetic Resonance in Clinically Suspected Cardiac Amyloidosis
Vogelsberg, H., Mahrholdt, H., Deluigi, C. C., Yilmaz, A., Kispert, E. M., Greulich, S., Klingel, K., Kandolf, R., & Sechtem, U. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.10.049 · Cited by 444
T1 mapping and survival in systemic light-chain amyloidosis
Banypersad, S. M., Fontana, M., Maestrini, V., Sado, D. M., Captur, G., Petrie, A., Piechnik, S. K., Whelan, C. J., Herrey, A. S., Gillmore, J. D., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu444 · Cited by 393
Self-citationCMR-Based Differentiation of AL and ATTR Cardiac Amyloidosis
Dungu, J. N., Valencia, O., Pinney, J. H., Gibbs, S. D. J., Rowczenio, D., Gilbertson, J. A., Lachmann, H. J., Wechalekar, A., Gillmore, J. D., Whelan, C. J., et al. (2014) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2013.08.015 · Cited by 344
Self-citation
Research works printed but not linked: 11
- 10.1182/blood-2012-12-473066 · doi:10.1182/blood-2012-12-473066
- 10.1136/hrt.78.1.74 · doi:10.1136/hrt.78.1.74
- 10.1161/01.CIR.0000068314.02595.B2 · doi:10.1161/01.cir.0000068314.02595.b2
- 10.1016/j.jcmg.2013.12.002 · doi:10.1016/j.jcmg.2013.12.002
- 10.1161/01.CIR.0000153623.02240.20 · doi:10.1161/01.cir.0000153623.02240.20
- 10.1016/j.amjmed.2010.03.022 · doi:10.1016/j.amjmed.2010.03.022
- 10.1002/mrm.10051 · doi:10.1002/mrm.10051
- 10.1186/1532-429X-14-88 · doi:10.1186/1532-429x-14-88
- 10.1016/j.jcmg.2012.04.006 · doi:10.1016/j.jcmg.2012.04.006
- 10.1111/joim.12324 · doi:10.1111/joim.12324
- Fontana M Banypersad SM Treibel TA Abdel-Gadir A Maestrini V Lane T Gilbertson JA Hutt DF Lachmann HJ Whelan CJ Wechalekar AD Herrey AS Gillmore JD Hawkins PN Moon JC. Differential myocyte responses in patients with cardiac transthyretin amyloidosis and light-chain amyloidosis: a cardiac MR imaging study [published online ahead of print May 21 2015]. Radiology. 2015 May 21:141744. doi: http://dx.doi.org/10.1148/radiol.2015141744. http://pubs.rsna.org/doi/10.1148/radiol.2015141744?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed&. Accessed September 20 2015. · doi:10.1148/radiol.2015141744
Cited by
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001063 · Cited by 4,922
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.12.012 · Cited by 2,862
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
Gillmore, J. D., Maurer, M. S., Falk, R. H., Merlini, G., Damy, T., Dispenzieri, A., Wechalekar, A. D., Berk, J. L., Quarta, C. C., Grogan, M., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.021612 · Cited by 2,081
Self-citationMessroghli, D. R., Moon, J. C., Ferreira, V. M., Grosse-Wortmann, L., He, T., Kellman, P., Mascherbauer, J., Nezafat, R., Salerno, M., Schelbert, E. B., et al. (2016) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-017-0389-8 · Cited by 1,727
Self-citationKusumoto, F. M., Schoenfeld, M. H., Barrett, C., Edgerton, J. R., Ellenbogen, K. A., Gold, M. R., Goldschlager, N. F., Hamilton, R. M., Joglar, J. A., Kim, R. J., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.10.044 · Cited by 1,008
A new staging system for cardiac transthyretin amyloidosis
Gillmore, J. D., Damy, T., Fontana, M., Hutchinson, M., Lachmann, H. J., Martinez-Naharro, A., Quarta, C. C., Rezk, T., Whelan, C. J., Gonzalez-Lopez, E., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx589 · Cited by 776
Self-citationAL (Light-Chain) Cardiac Amyloidosis
Falk, R. H., Alexander, K. M., Liao, R., & Dorbala, S. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.06.053 · Cited by 649
Kusumoto, F. M., Schoenfeld, M. H., Barrett, C., Edgerton, J. R., Ellenbogen, K. A., Gold, M. R., Goldschlager, N. F., Hamilton, R. M., Joglar, J. A., Kim, R. J., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000628 · Cited by 603
Dorbala, S., Ando, Y., Bokhari, S., Dispenzieri, A., Falk, R. H., Ferrari, V. A., Fontana, M., Gheysens, O., Gillmore, J. D., Glaudemans, A. W. J. M., et al. (2019) · Journal of Nuclear Cardiology · doi:10.1007/s12350-019-01760-6 · Cited by 484
Self-citationMagnetic Resonance in Transthyretin Cardiac Amyloidosis
Martinez-Naharro, A., Treibel, T. A., Abdel-Gadir, A., Bulluck, H., Zumbo, G., Knight, D. S., Kotecha, T., Francis, R., Hutt, D. F., Rezk, T., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.05.053 · Cited by 437
Self-citationCastano, A., Haq, M., Narotsky, D. L., Goldsmith, J., Weinberg, R. L., Morgenstern, R., Pozniakoff, T., Ruberg, F. L., Miller, E. J., Berk, J. L., et al. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.2839 · Cited by 424
2020 Clinical practice guidelines for Chronic heart failure
Russian Society of Cardiology (RSC) (2020) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2020-4083 · Cited by 395
Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis
Maurer, M. S., Kale, P., Fontana, M., Berk, J. L., Grogan, M., Gustafsson, F., Hung, R. R., Gottlieb, R. L., Damy, T., González-Duarte, A., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2300757 · Cited by 339
Self-citationKusumoto, F. M., Schoenfeld, M. H., Barrett, C., Edgerton, J. R., Ellenbogen, K. A., Gold, M. R., Goldschlager, N. F., Hamilton, R. M., Joglar, J. A., Kim, R. J., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.10.043 · Cited by 337
Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment
Siddiqi, O. K., & Ruberg, F. L. (2018) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2017.07.004 · Cited by 333
Restrictive Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy
Muchtar, E., Blauwet, L. A., & Gertz, M. A. (2017) · Circulation Research · doi:10.1161/circresaha.117.310982 · Cited by 327
Systemic amyloidosis from A (AA) to T (ATTR): a review
Muchtar, E., Dispenzieri, A., Magen, H., Grogan, M., Mauermann, M., McPhail, E. D., Kurtin, P. J., Leung, N., Buadi, F. K., Dingli, D., et al. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13169 · Cited by 327
Treibel, T. A., Fontana, M., Gilbertson, J. A., Castelletti, S., White, S. K., Scully, P. R., Roberts, N., Hutt, D. F., Rowczenio, D. M., Whelan, C. J., et al. (2016) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.116.005066 · Cited by 317
Self-citationRole of Cardiac Magnetic Resonance in the Diagnosis and Prognosis of Nonischemic Cardiomyopathy
Patel, A. R., & Kramer, C. M. (2017) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2017.08.005 · Cited by 313
How to Image Cardiac Amyloidosis
Dorbala, S., Cuddy, S., & Falk, R. H. (2020) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2019.07.015 · Cited by 308
Pagourelias, E. D., Mirea, O., Duchenne, J., Van Cleemput, J., Delforge, M., Bogaert, J., Kuznetsova, T., & Voigt, J.-U. (2017) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.116.005588 · Cited by 306
Dorbala, S., Ando, Y., Bokhari, S., Dispenzieri, A., Falk, R. H., Ferrari, V. A., Fontana, M., Gheysens, O., Gillmore, J. D., Glaudemans, A. W. J. M., et al. (2021) · Circulation: Cardiovascular Imaging · doi:10.1161/hci.0000000000000029 · Cited by 275
Self-citationMultiparametric Echocardiography Scores for the Diagnosis of Cardiac Amyloidosis
Boldrini, M., Cappelli, F., Chacko, L., Restrepo-Cordoba, M. A., Lopez-Sainz, A., Giannoni, A., Aimo, A., Baggiano, A., Martinez-Naharro, A., Whelan, C., et al. (2020) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2019.10.011 · Cited by 268
Self-citationMartinez-Naharro, A., Hawkins, P. N., & Fontana, M. (2018) · Clinical Medicine · doi:10.7861/clinmedicine.18-2-s30 · Cited by 257
Self-citationKusumoto, F. M., Schoenfeld, M. H., Barrett, C., Edgerton, J. R., Ellenbogen, K. A., Gold, M. R., Goldschlager, N. F., Hamilton, R. M., Joglar, J. A., Kim, R. J., et al. (2019) · Heart Rhythm · doi:10.1016/j.hrthm.2018.10.037 · Cited by 131
Metadata
- Authors
- Fontana, M., Pica, S., Reant, P., Abdel-Gadir, A., Treibel, T. A., Banypersad, S. M., Maestrini, V., Barcella, W., Rosmini, S., Bulluck, H., Sayed, R. H., Patel, K., Mamhood, S., Bucciarelli-Ducci, C., Whelan, C. J., Herrey, A. S., Lachmann, H. J., Wechalekar, A. D., Manisty, C. H., Schelbert, E. B., Kellman, P., Gillmore, J. D., Hawkins, P. N., & Moon, J. C.
- Venue
- Circulation
- Published
- 2015-10-20
- Volume
- 132
- Issue
- 16
- Pages
- 1570-1579
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1769623626
- Cited by
- 626
- References
- 16
- FWCI
- 19.94
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.